Cargando…
HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway by regulating MSK1 and PPP2R2B
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, which lacks effective therapies. Here, we demonstrate that the transcription factor, homeobox C6 (HOXC6), is overexpressed in most PDACs, and its inhibition blocks PDAC tumor growth and metastasis. HOXC6 transcriptionally activ...
Autores principales: | Malvi, Parmanand, Chava, Suresh, Cai, Guoping, Hu, Kai, Zhu, Lihua Julie, Edwards, Yvonne J.K., Green, Michael R., Gupta, Romi, Wajapeyee, Narendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694669/ https://www.ncbi.nlm.nih.gov/pubmed/37951219 http://dx.doi.org/10.1016/j.xcrm.2023.101285 |
Ejemplares similares
-
LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1
por: Malvi, Parmanand, et al.
Publicado: (2020) -
Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor–resistant pancreatic ductal adenocarcinoma
por: Malvi, Parmanand, et al.
Publicado: (2022) -
PSPH promotes melanoma growth and metastasis by metabolic-deregulation–mediated transcriptional activation of NR4A1
por: Rawat, Vipin, et al.
Publicado: (2021) -
Co-targeting of specific epigenetic regulators in combination with CDC7 potently inhibit melanoma growth
por: Chava, Suresh, et al.
Publicado: (2022) -
Loss of thymidine kinase 1 inhibits lung cancer growth and metastatic attributes by reducing GDF15 expression
por: Malvi, Parmanand, et al.
Publicado: (2019)